2023
Communications orales
- Intra articular injection(s) of active bacteriophages as adjuvant therapy in patients with PJI qualified for open or arthroscopic DAIR followed by suppressive antimicrobial therapy (SAT)
- Exclusive medical treatment combining intraarticular injections of active bacteriophages as adjuvant therapy to antibiotics in patients with S. aureus complex PJI contraindicated for, or refusing, surgery
2022
Publications
- Les virus au service de la santé : les bactériophages
- Paving the way for phage therapy using novel drug delivery approaches
- Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years’ experience
2021
Publications
- Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
- Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
Communications orales
Posters
- IMPLEMENTATION OF A PHAGE THERAPY CENTER IN FRANCE DEDICATED TO COMPLEX BONE AND JOINT INFECTION: 4-YEAR EXPERIENCE OF MULTIDISCIPLINARITY AND MULTISTEP INTERACTIONS
- Mise en place d’un centre de phagothérapie en France dédié aux infections ostéo-articulaires complexes : 4 ans d’expérience de multidisciplinarité et d’interactions multi-étapes
- Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort study
- Implementation of a phage therapy center in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactions